Riley E M, Rowe P, Allen S J, Greenwood B M
Medical Research Council Laboratories, Fajara, The Gambia.
Clin Exp Immunol. 1993 Mar;91(3):495-9. doi: 10.1111/j.1365-2249.1993.tb05930.x.
Plasma levels of soluble IL-2 receptor (sIL-2R) were measured by immunoassay in 180 individuals, aged 1-70 years, living in a malaria-endemic community in West Africa. sIL-2R levels were compared with age, malaria parasitaemia, malaria-associated morbidity and cellular immune responses to Plasmodium falciparum antigens. Plasma levels of sIL-2R were independently associated with both age and patent malaria parasitaemia. No significant association was observed between IL-2R levels and concurrent malaria morbidity (i.e. fever associated with malaria), but the number of individuals with clinical malaria at the time of sampling was small. Although there was no association between plasma sIL-2R levels and in vitro proliferative responses of peripheral blood mononuclear cells (PBMC) to a number of defined malaria antigens, we did find a significant negative association between sIL-2R and in vitro proliferation of unstimulated PBMC. High levels of sIL-2R (up to 5500 U/ml) were detected in the plasma of malaria-infected individuals; this is indicative of a vigorous cellular immune response to malaria antigens in vivo and does not support the notion that malaria infections are generally immunosuppressive. Indeed, we found that, at the low levels of parasitaemia present in study subjects, there was no significant difference in the mean proliferative response to malaria antigens in infected subjects when compared with uninfected subjects.
采用免疫分析法检测了居住在西非疟疾流行社区的180名年龄在1至70岁之间个体的血浆可溶性白细胞介素-2受体(sIL-2R)水平。将sIL-2R水平与年龄、疟疾寄生虫血症、疟疾相关发病率以及对恶性疟原虫抗原的细胞免疫反应进行了比较。血浆sIL-2R水平与年龄和现患疟疾寄生虫血症均独立相关。未观察到IL-2R水平与同时发生的疟疾发病率(即与疟疾相关的发热)之间存在显著关联,但采样时患有临床疟疾的个体数量较少。尽管血浆sIL-2R水平与外周血单个核细胞(PBMC)对多种特定疟疾抗原的体外增殖反应之间无关联,但我们确实发现sIL-2R与未刺激的PBMC体外增殖之间存在显著负相关。在疟疾感染个体的血浆中检测到高水平的sIL-2R(高达5500 U/ml);这表明体内对疟疾抗原存在强烈的细胞免疫反应,并不支持疟疾感染通常具有免疫抑制作用的观点。事实上,我们发现,在研究对象中存在的低水平寄生虫血症情况下,与未感染个体相比,感染个体对疟疾抗原的平均增殖反应无显著差异。